# Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage

> **NCT06673602** · PHASE4 · RECRUITING · sponsor: **Qinhuangdao Hospital of Traditional Chinese Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Cognitive Impairment
- Intracerebral Hemorrhage

## Interventions

- **DRUG:** FCYC+Conventional treatment
- **DRUG:** conventional treatment

## Key facts

- **NCT ID:** NCT06673602
- **Lead sponsor:** Qinhuangdao Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-04
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06673602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06673602, "Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06673602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*